Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734

Bromodomain and extra-terminal domain (BET) proteins, cyclic adenosine monophosphate response element-binding protein (CBP), and the E1A-binding protein of p300 (EP300) are important players in histone acetylation. Preclinical evidence supports the notion that small molecules targeting these protein...

詳細記述

保存先:
書誌詳細
出版年:Blood Adv
主要な著者: Spriano, Filippo, Gaudio, Eugenio, Cascione, Luciano, Tarantelli, Chiara, Melle, Federica, Motta, Giovanna, Priebe, Valdemar, Rinaldi, Andrea, Golino, Gaetanina, Mensah, Afua Adjeiwaa, Aresu, Luca, Zucca, Emanuele, Pileri, Stefano, Witcher, Michael, Brown, Bill, Wahlestedt, Claes, Giles, Francis, Stathis, Anastasios, Bertoni, Francesco
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Hematology 2020
主題:
Lymphoid Neoplasia
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7479962/
https://ncbi.nlm.nih.gov/pubmed/32882003
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001879
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料